Document:

EX-10.1

 Exhibit 10.1 

FORM OF SPONSOR SUPPORT AGREEMENT 

This Sponsor Support Agreement (this “Sponsor Agreement”) is dated as of April 26, 2022, by and
among Isleworth Healthcare Sponsor I, LLC, a Delaware limited liability company (the “Sponsor Holdco”), the persons set forth on Schedule I hereto (together with the Sponsor Holdco, each, a
“Sponsor” and, together, the “Sponsors”), Isleworth Healthcare Acquisition Corp., a Delaware corporation (“Parent”), and Cytovia Holdings, Inc., a Delaware corporation (the
“Company”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below). 

RECITALS 
 WHEREAS, as of
the date hereof, the Sponsors collectively are the holders of record and “beneficial owners” (within the meaning of Rule 13d-3 of the Exchange Act) of 5,175,000 shares of Parent Common Stock and
4,912,000 Parent Warrants in the aggregate as set forth on Schedule I attached hereto (collectively, the “Parent Securities”); 

WHEREAS, concurrently with the execution of this Sponsor Agreement, Parent, IHAC First Merger Sub, Inc., a Delaware corporation
(“First Merger Sub”), IHAC Second Merger Sub LLC, a Delaware limited liability company (“Second Merger Sub”) and the Company entered into a Merger Agreement and Plan of Reorganization (as amended or
modified from time to time, the “Merger Agreement”) pursuant to which, among other transactions, First Merger Sub will merge with and into the Company (the “First Merger”), with the Company surviving
the First Merger as a wholly owned subsidiary of Parent (the Company, in its capacity as the surviving corporation of the First Merger, is sometimes referred to as the “Surviving Corporation”), and immediately following the
First Merger, the Surviving Corporation will merge with and into Second Merger Sub (the “Second Merger” and, together with the First Merger, the “Mergers”), with Second Merger Sub being the surviving
entity of the Second Merger, on the terms and conditions set forth therein; and 
 WHEREAS, as an inducement to Parent and the Company to
enter into the Merger Agreement and to consummate the Transactions, the parties hereto desire to agree to certain matters as set forth herein. 

AGREEMENT 
 NOW, THEREFORE,
in consideration of the foregoing and the mutual agreements contained herein, and intending to be legally bound hereby, the parties hereto hereby agree as follows: 

ARTICLE I 
 SPONSOR
SUPPORT AGREEMENT; COVENANTS 
 Section 1.1    No Transfer. During the period commencing on the date
hereof and ending on the earlier to occur of (a) the Effective Time and (b) such date and time as the Merger Agreement shall be terminated in accordance with Section 9.01 thereof (the earlier of (a) and (b), the
“Expiration Time”), each Sponsor shall not (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of,

 
directly or indirectly, file (or participate in the filing of) a registration statement with the SEC (other than the Proxy Statement and Registration Statement) or establish or increase a put
equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, with respect to any Parent Securities owned by such Sponsor, (ii) enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of any Parent Securities owned by such Sponsor (each transaction specified in clauses (i) and (ii), a “Transfer”) or
(iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii); provided, however, that (x) a Sponsor may Transfer his, her or its Parent Securities (A) to any other Sponsor that has
entered into or otherwise agreed to be bound by this Sponsor Agreement or (B) to Private Placement Investors or to holders of Parent Common Stock in accordance with Section 7.10(f) of the Merger Agreement, subject to the transferee’s
entry into a binding non-redemption agreement in connection with such Transfer that includes a waiver of Redemption Rights, or (y) (A) if a Sponsor is an individual, such Sponsor may Transfer any such
Parent Securities (1) to any member of such Sponsor’s immediate family, or to a trust for the benefit of such Sponsor or any member of such Sponsor’s immediate family, the sole trustees of which are such Sponsor or any member of such
Sponsor’s immediate family or (2) by will, other testamentary document or under the laws of intestacy upon the death of such Sponsor; or (B) if a Sponsor is an entity, such Sponsor may Transfer any Parent Securities to any partner,
member, or affiliate of such Sponsor in accordance with the terms of the Parent Certificate of Incorporation; provided further, that in each case such transferee of such Parent Securities evidences in a writing reasonably satisfactory
to the Company such transferee’s agreement to be bound by and subject to the terms and provisions hereof to the same extent as the Sponsor. 

Section 1.2    New Shares. In the event that, during the period commencing on the date hereof and ending at
the Expiration Time, (a) any Parent Securities or other equity securities of Parent are issued to a Sponsor after the date of this Sponsor Agreement pursuant to any stock dividend, stock split, recapitalization, reclassification, combination or
exchange of Parent Securities owned by such Sponsor or otherwise, (b) a Sponsor purchases or otherwise acquires beneficial ownership of any Parent Securities or other equity securities of Parent after the date of this Sponsor Agreement, or
(c) a Sponsor acquires the right to vote or share in the voting of any shares of Parent Common Stock or other equity securities of Parent after the date of this Sponsor Agreement (collectively, the “New Securities”), then such
New Securities acquired or purchased by such Sponsor shall be subject to the terms of this Sponsor Agreement to the same extent as if they constituted Parent Securities owned by such Sponsor as of the date hereof. 

Section 1.3    Closing Date Deliverable. On the Closing Date, each Sponsor that is a Parent Initial
Stockholder shall deliver to Parent and the Company a duly executed copy of that certain Amended and Restated Registration Rights Agreement, in a form to be agreed to by the parties. 

Section 1.4    Sponsor Agreements. 

(a)    Hereafter until the Expiration Time, each Sponsor hereby unconditionally and irrevocably agrees that, at any
meeting of the stockholders of Parent (or any adjournment or postponement thereof), or in any other circumstance in which the vote, consent or other approval of the shareholders of Parent is sought, each Sponsor shall (i) appear at each such
meeting or otherwise cause all of its shares of Parent Common Stock to be counted as present 

  
 2 

 
thereat for purposes of establishing a quorum and (ii) vote (or cause to be voted), or execute and deliver a written consent (or cause a written consent to be executed and delivered)
covering, all of its shares of Parent Common Stock: 
 (i)    in favor of each Parent Proposal,
including, without limitation, the approval and adoption of the Merger Agreement, the Mergers and the other Transaction Documents and the transactions contemplated thereby; 

(ii)    against any Business Combination Proposal or any proposal relating to a Business Combination
Proposal (in each case, other than the Parent Proposals); 
 (iii)    against any merger agreement or
merger (other than the Merger Agreement and the Mergers), consolidation, combination, sale of substantial assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by Parent; 

(iv)    against any change in the business, management or the Parent Board (other than in connection with
the Parent Proposals); 
 (v)    against any proposal, action or agreement that would (i) impede,
frustrate, prevent or nullify any provision of this Sponsor Agreement, the Merger Agreement or any Merger, (ii) result in a breach in any respect of any covenant, representation, warranty or any other obligation or agreement of Parent, First
Merger Sub or Second Merger Sub under the Merger Agreement, (iii) result in any of the conditions set forth in Article VIII of the Merger Agreement not being fulfilled prior to the Outside Date, or (iv) change in any manner the dividend
policy or capitalization of, including the voting rights of any class of capital stock of, Parent; and 

(vi)    to approve or authorize (or to vote against or withhold consent for, as applicable) any other
matters necessary or reasonably requested by the Company or Parent for the consummation of the Transactions; 
 provided, however, that such
Sponsor shall not vote or provide consent with respect to any of its Parent Securities or New Securities that have the power to vote (including, without limitation, by proxy or power of attorney) that are not held by Parent’s directors,
officers, affiliates or greater than 5% shareholders of Parent, or take any other action, in each case to the extent any such vote, consent or other action would preclude Parent from filing the Registration Statement with the SEC as contemplated by
the Merger Agreement. Each Sponsor hereby agrees that it shall not commit or agree to take any action inconsistent with the foregoing prior to the Expiration Time. 

(b)    Each Sponsor shall not redeem any shares of Parent Common Stock owned by such Sponsor in connection with the
transactions contemplated by the Merger Agreement and shall comply with, and fully perform all of his, her or its obligations, covenants and agreements set forth in that certain Letter Agreement, dated February 24, 2021, by and among the
Sponsors and Parent (the “Voting Letter Agreement”). 

  
 3 

 (c)    During the period commencing on the date hereof and ending on
the earlier of the consummation of the Closing and the termination of the Merger Agreement pursuant to Section 9.01 thereof, each Sponsor shall not modify or amend any Contract between or among such Sponsor, anyone related by blood, marriage or
adoption to such Sponsor or any Affiliate of such Sponsor (other than Parent or any of its Subsidiaries), on the one hand, and Parent or any of its Subsidiaries, on the other hand (including, for the avoidance of doubt, the Voting Letter Agreement)
without the Company’s prior written consent. 
 (d)    Each Sponsor hereby acknowledges that the Amended and
Restated Bylaws of Parent in a form to be agreed by the parties (the “Amended Bylaws”) shall provide that the shares of Parent Common Stock will be subject to Transfer restrictions (i.e., a
“lock-up”) following the Closing. Accordingly, each Sponsor hereby agrees to be bound by and comply with the Amended Bylaws as if such Transfer restrictions was set forth herein and made a part
hereof. 
 (e)    Each Sponsor agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all
actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, First Merger Sub, Second Merger Sub, the Company or any of their respective successors or directors
(i) challenging the validity of, or seeking to enjoin the operation of, any provision of this Sponsor Agreement or (ii) alleging a breach of any fiduciary duty of any person in connection with the evaluation, negotiation or entry into the
Merger Agreement. Each Sponsor hereby irrevocably and unconditionally waives, and agrees not to assert, exercise or perfect (or attempt to exercise, assert or perfect), any rights of appraisal or rights to dissent from the First Merger or appraisal
or dissenters’ rights that it may at any time have under applicable Laws, including Section 262 of the DGCL. 

(f)    Each Sponsor hereby consents to the publication and disclosure in the Proxy Statement and Registration Statement
(and, as and to the extent otherwise required by applicable securities Laws or the SEC or any other securities authorities, any other documents or communications provided by Parent or the Company to any Governmental Authority or to securityholders
of Parent) of such Sponsor’s identity and beneficial ownership of Parent Securities and the nature of such Sponsor’s commitments, arrangements and understandings under and relating to this Sponsor Agreement and, if deemed appropriate by
Parent or the Company, a copy of this Sponsor Agreement. Each Sponsor will promptly provide any information reasonably requested by Parent or the Company for any regulatory application or filing made or approval sought in connection with the
Transactions (including filings with the SEC). 
 (g)    Upon the failure of a Sponsor to vote (or cause to be voted),
or execute and deliver a written consent (or cause a written consent to be executed and delivered) covering, all of such Sponsor’s shares of Parent Common Stock in accordance with Section 1.4 of this Sponsor Agreement
at any meeting of the stockholders of Parent (or any adjournment or postponement thereof), or in any other circumstance in which the vote, consent or other approval of the shareholders of Parent is sought, such Sponsor shall be deemed to have
irrevocably granted to, and appointed, Parent, and any designee thereof, and each of them individually, as such Sponsor’s proxy and attorney-in-fact (with full
power of substitution), for and in such Sponsor’s name, place and stead, to include such Sponsor’s Parent Common Stock in any computation for purposes of establishing a quorum at any such meeting of the stockholders of Parent and to
provide consent or vote such Sponsor’s Parent Common Stock in any action by written consent of the 

  
 4 

 
stockholders of Parent or at any meeting of the stockholders of Parent called with respect to any of the matters specified in, and in accordance and consistent with,
Section 1.4 of this Sponsor Agreement. Each Sponsor hereby affirms that the irrevocable proxy is coupled with an interest and may under no circumstances be revoked and that such irrevocable proxy is executed and intended to
be irrevocable. Notwithstanding any other provision of this Sponsor Agreement, the irrevocable proxy granted hereunder shall automatically terminate upon the termination of this Sponsor Agreement. 

Section 1.5    Anti-Dilution Waiver. Each Sponsor hereby waives, to the fullest extent permitted by Law,
(i) any rights of anti-dilution applicable to the issuance of shares of Parent Common Stock in connection with the Transactions and (ii) any rights under any Contract or other arrangement with Parent to convert all or any portion of any
amounts loaned or advanced to Parent or its Subsidiaries at any time prior to or at the Closing into warrants to purchase Parent Common Stock. This waiver shall be applicable only in connection with the Transactions and shall be void and of no force
and effect following the Expiration Time. 
 Section 1.6    Binding Effect of Merger Agreement. Each
Sponsor shall be bound by and comply with Sections 7.06 (Exclusivity) and 7.11 (Public Announcements) of the Merger Agreement (and any relevant definitions contained in any such Sections) as if (a) such Sponsor was an original
signatory to the Merger Agreement with respect to such provisions, and (b) each reference to “Parent” in Section 7.06 of the Merger Agreement also referred to each Sponsor. 

Section 1.7    Further Assurances. Each Sponsor shall execute and deliver, or cause to be delivered, such
additional documents, and take, or cause to be taken, all such further actions and do, or cause to be done, all things reasonably necessary (including under applicable Laws), or reasonably requested by Parent or the Company, to effect the actions
and consummate the Mergers and the other transactions contemplated by this Sponsor Agreement and the Merger Agreement (including the Transactions), in each case, on the terms and subject to the conditions set forth therein and herein, as applicable.

 Section 1.8    No Inconsistent Agreement. Each Sponsor hereby represents and covenants that such Sponsor
(i) has not entered into, and shall not enter into, any voting agreement, voting trust or other agreement with respect to any of such Sponsor’s Parent Securities that is inconsistent with such Sponsor’s obligations pursuant to this
Sponsor Agreement or any agreement or amendment of an existing agreement that would restrict, limit or interfere with the performance of such Sponsor’s obligations hereunder, and (ii) has not granted, and shall not grant, a proxy, power of
attorney or similar right with respect to any of such Sponsor’s Parent Securities that is inconsistent with such Sponsor’s obligations pursuant to this Sponsor Agreement. 

Section 1.9    Release of Claims. Effective as of, and conditioned upon occurrence of, the Closing, each
Sponsor, for himself, herself or itself and on behalf of each of his, her or its Affiliates and each of their respective successors (each, a “Releasing Party”), hereby unequivocally, voluntarily, knowingly, willingly,
unconditionally, completely and, irrevocably releases, acquits, exculpates and forever waives and relinquishes all claims, suits, debts, demands, liabilities, setoffs, counterclaims, actions, manners of action and causes of action of whatever kind
or nature, whether known or unknown (collectively, “Claims”), which any Releasing Party has, may have or might have or may assert now or in the future, against Parent, the Company and their

  
 5 

 
respective Subsidiaries and Representatives (in each case, solely in their capacity as such), successors and permitted assigns, and each of their respective officers, directors, owners, partners,
managers or employees (in each case, solely in their capacity as such) (collectively, the “Released Parties”) to the extent arising out of, based upon or resulting from any Contract, transaction, event, circumstance, action,
failure to act or occurrence of any sort or type, whether known or unknown, and which, in each and every case, occurred, existed, was taken, permitted, incurred or begun at or prior to the Closing, in each case solely with regard to Parent, the
business or operations of Parent prior to the Closing or the Transactions; provided that nothing contained in this Section 1.9 shall be construed as a waiver of any rights under (i) this Sponsor Agreement,
(ii) any other Transaction Document to which any Releasing Party is party, (iii) if such Sponsor is an employee of Parent, rights to accrued but unpaid salary, bonuses, expense reimbursements (in accordance with Parent’s employee
expense reimbursement policy), accrued vacation and other benefits under Parent’s employee benefit plans, or (iv) any indemnification, employment or other similar arrangements (including any such arrangement providing for exculpation or
advancement of expenses), including any rights to indemnification, exculpation, advancement of expense or similar rights set forth in the Parent Organizational Documents, any indemnification agreement between Parent and such Sponsor, or as provided
by law or any directors’ and officers’ liability insurance. 
 ARTICLE II 

REPRESENTATIONS AND WARRANTIES 

Section 2.1    Representations and Warranties of the Sponsors. Each Sponsor represents and warrants as of the
date hereof to Parent and the Company (solely with respect to itself, himself or herself and not with respect to any other Sponsor) as follows: 

(a)    Organization; Due Authorization. If such Sponsor is not an individual, it is duly organized, validly
existing and in good standing under the Laws of the jurisdiction in which it is incorporated, formed, organized or constituted, and the execution, delivery and performance of this Sponsor Agreement and the consummation of the transactions
contemplated hereby are within such Sponsor’s corporate, limited liability company or organizational powers and have been duly authorized by all necessary corporate, limited liability company or organizational actions on the part of such
Sponsor. If such Sponsor is an individual, such Sponsor has full legal capacity, right and authority to execute and deliver this Sponsor Agreement and to perform his or her obligations hereunder. This Sponsor Agreement has been duly executed and
delivered by such Sponsor and, assuming due authorization, execution and delivery by the other parties to this Sponsor Agreement, this Sponsor Agreement constitutes a legally valid and binding obligation of such Sponsor, enforceable against such
Sponsor in accordance with the terms hereof (subject to the Remedies Exceptions). If this Sponsor Agreement is being executed in a representative or fiduciary capacity, the person signing this Sponsor Agreement has full power and authority to enter
into this Sponsor Agreement on behalf of the applicable Sponsor. 
 (b)    Ownership. Such Sponsor is the record
and beneficial owner (as defined in the Securities Act) of, and has good title to, all of such Sponsor’s Parent Securities, and there exist no Liens or any other limitation or restriction (including any restriction on the right to vote, sell or
otherwise dispose of such Parent Securities (other than transfer restrictions under the Securities Act) affecting any such Parent Securities, other than Liens pursuant to (i) this Sponsor 

  
 6 

 
Agreement, (ii) the Parent Organizational Documents, (iii) the Merger Agreement, (iv) the Voting Letter Agreement or (v) any applicable securities Laws. Such Sponsor’s
Parent Securities are the only equity securities in Parent owned of record or beneficially by such Sponsor on the date of this Sponsor Agreement, and none of such Sponsor’s Parent Securities are subject to any proxy, voting trust or other
agreement or arrangement with respect to the voting of such Parent Securities, except as provided hereunder and under the Voting Letter Agreement. Other than the Parent Warrants, such Sponsor does not hold or own any rights to acquire (directly or
indirectly) any equity securities of Parent or any equity securities convertible into, or which can be exchanged for, equity securities of Parent. 

(c)    No Conflicts. The execution and delivery of this Sponsor Agreement by such Sponsor does not, and the
performance by such Sponsor of his, her or its obligations hereunder will not, (i) if such Sponsor is not an individual, conflict with or result in a violation of the organizational documents of such Sponsor or (ii) require any consent or
approval that has not been given or other action that has not been taken by any person (including under any Contract binding upon such Sponsor or such Sponsor’s Parent Securities), in each case, to the extent such consent, approval or other
action would prevent, enjoin or materially delay the performance by such Sponsor of its, his or her obligations under this Sponsor Agreement. 

(d)    Litigation. There are no Actions pending against such Sponsor, or to the knowledge of such Sponsor
threatened against such Sponsor, before (or, in the case of threatened Actions, that would be before) any arbitrator or any Governmental Authority, which in any manner challenges or seeks to prevent, enjoin or materially delay the performance by
such Sponsor of its, his or her obligations under this Sponsor Agreement. 
 (e)    Brokerage Fees. Except as
set forth on Section 5.12 of the Parent Disclosure Schedule, no broker, finder, investment banker or other person is entitled to any brokerage fee, finders’ fee or other commission in connection with the Transactions based upon
arrangements made by such Sponsor, for which Parent or any of its Subsidiaries may become liable. 

(f)    Affiliate Arrangements. Except as set forth on Schedule II attached hereto, neither such Sponsor nor
any anyone related by blood, marriage or adoption to such Sponsor or, to the knowledge of such Sponsor, any person in which such Sponsor has a direct or indirect legal, contractual or beneficial ownership of 5% or greater is party to, or has any
rights with respect to or arising from, any Contract with Parent or its Subsidiaries. 
 (g)    Acknowledgment.
Such Sponsor understands and acknowledges that each of Parent and the Company is entering into the Merger Agreement in reliance upon such Sponsor’s execution and delivery of this Sponsor Agreement. 

ARTICLE III 

MISCELLANEOUS 

Section 3.1    Termination. This Sponsor Agreement and all of its provisions shall terminate and be of no
further force or effect upon the earlier of (i) the Expiration Time and (ii) as to each Sponsor, the written agreement of the Sponsor, Parent, and the Company. Upon such 

  
 7 

 
termination of this Sponsor Agreement, all obligations of the parties under this Sponsor Agreement will terminate, without any liability or other obligation on the part of any party hereto to any
person in respect hereof or the transactions contemplated hereby, and no party hereto shall have any claim against another (and no person shall have any rights against such party), whether under contract, tort or otherwise, with respect to the
subject matter hereof; provided, however, that the termination of this Sponsor Agreement shall not relieve any party hereto from liability arising in respect of any breach of this Sponsor Agreement prior to such termination. This ARTICLE III
shall survive the termination of this Sponsor Agreement. 
 Section 3.2    Governing Law. This Sponsor
Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed in and to be performed in that State. All legal actions and proceedings arising out of or relating to this Sponsor
Agreement shall be heard and determined exclusively in any Delaware Chancery Court; provided, that if jurisdiction is not then available in the Delaware Chancery Court, then any such legal Action may be brought in any federal court located in
the State of Delaware or any other Delaware state court. The parties hereto hereby (a) irrevocably submit to the exclusive jurisdiction of the aforesaid courts for themselves and with respect to their respective properties for the purpose of
any Action arising out of or relating to this Sponsor Agreement brought by any party hereto, and (b) agree not to commence any Action relating thereto except in the courts described above in Delaware, other than Actions in any court of
competent jurisdiction to enforce any judgment, decree or award rendered by any such court in Delaware as described herein. Each of the parties further agrees that notice as provided herein shall constitute sufficient service of process and the
parties further waive any argument that such service is insufficient. Each of the parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Action arising out
of or relating to this Sponsor Agreement or the transactions contemplated hereby, (i) any claim that it is not personally subject to the jurisdiction of the courts in Delaware as described herein for any reason, (ii) that it or its
property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment
or otherwise) and (iii) that (x) the Action in any such court is brought in an inconvenient forum, (y) the venue of such Action is improper or (z) this Sponsor Agreement, or the subject matter hereof, may not be enforced in or by
such courts. 
 Section 3.3    WAIVER OF JURY TRIAL. Each of the parties hereto hereby waives to the fullest
extent permitted by applicable Law any right it may have to a trial by jury with respect to any litigation directly or indirectly arising out of, under or in connection with this Sponsor Agreement or the Transactions. Each of the parties hereto
(a) certifies that no representative, agent or attorney of any other party has represented, expressly or otherwise, that such other party would not, in the event of litigation, seek to enforce that foregoing waiver and (b) acknowledges
that it and the other hereto have been induced to enter into this Sponsor Agreement and the Transactions, as applicable, by, among other things, the mutual waivers and certifications in this Section 3.3. 

Section 3.4    Assignment. This Sponsor Agreement and all of the provisions hereof will be binding upon and
inure to the benefit of the parties hereto and their respective heirs, successors and permitted assigns. Neither this Sponsor Agreement nor any of the rights, interests 

  
 8 

 
or obligations hereunder will be assigned (including by operation of law) without the prior written consent of the parties hereto. 

Section 3.5    Specific Performance. The parties agree that irreparable damage would occur if any provision of
this Sponsor Agreement were not performed in accordance with the terms hereof, and, accordingly, that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Sponsor Agreement or to enforce specifically the
performance of the terms and provisions hereof in the Court of Chancery of the State of Delaware or, if that court does not have jurisdiction, any court of the United States located in the State of Delaware without proof of actual damages or
otherwise, in addition to any other remedy to which they are entitled at law or in equity as expressly permitted in this Sponsor Agreement. Each of the parties hereby further waives (i) any defense in any action for specific performance that a
remedy at law would be adequate and (ii) any requirement under any Law to post security or a bond as a prerequisite to obtaining equitable relief. 

Section 3.6    Amendment; Waiver. This Sponsor Agreement may not be amended, changed, supplemented,
waived or otherwise modified or terminated, except upon the execution and delivery of a written agreement executed by Parent, the Company and the Sponsor Holdco. 

Section 3.7    Severability. If any provision of this Sponsor Agreement is held invalid or unenforceable by
any court of competent jurisdiction, the other provisions of this Sponsor Agreement will remain in full force and effect. Any provision of this Sponsor Agreement held invalid or unenforceable only in part or degree will remain in full force and
effect to the extent not held invalid or unenforceable. 
 Section 3.8    Notices. All notices, requests,
claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by email or by registered or certified mail (postage prepaid, return receipt
requested) to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 3.8: 

If to Parent: 
 Isleworth
Healthcare Acquisition Corp. 
 360 Central Avenue, First Central Tower, Suite 800 

St. Petersburg, Florida 33701 

Attention: Dan Halvorson 
 Email:
dan@isleworthhealthcare.com 
 with a copy to (which will not constitute notice): 

ArentFox Schiff LLP 
 1717 K
Street NW 
 Washington, DC 20006 

  
 9 

 Attention: Ralph V. De Martino 

Email: RDeMartino@schiffhardin.com 

If to the Company: 

Cytovia Holdings, Inc. 
 18851 NE
29th Ave, 2nd Floor 
 Aventura, Florida 33180 

Attention: Elysa Mantel 
 Email:
emantel@cytoviatx.com 
 with a copy to (which shall not constitute notice): 

Cooley LLP 
 55 Hudson Yards 

New York, NY 10001-2157 

Attention: Josh Kaufman and David Silverman 

Email:    josh.kaufman@cooley.com and dsilverman@cooley.com 

If to a Sponsor: 
 To such
Sponsor’s address set forth in Schedule I. 
 Section 3.9    Counterparts. This Sponsor Agreement
may be executed in two or more counterparts (any of which may be delivered by electronic transmission), each of which shall constitute an original, and all of which taken together shall constitute one and the same instrument. 

Section 3.10    Entire Agreement. This Sponsor Agreement and the agreements referenced herein constitute the
entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersede all prior understandings, agreements or representations by or among the parties hereto to the extent they relate in any way to the subject
matter hereof. 
 [THE REMAINDER OF THIS PAGE IS INTENTIONALLY BLANK] 

  
 10 

 IN WITNESS WHEREOF, the Sponsors, Parent, and the Company have each caused this Sponsor
Support Agreement to be duly executed as of the date first written above. 
  

					
	SPONSORS:
	
	ISLEWORTH HEALTHCARE SPONSOR I, LLC
		
	By:	 	  

		 	Name:	 	Robert Whitehead
		 	Title:	 	Chief Executive Officer

 
					
	
	  

	Name:	 	W. Robert Dahl
	
	  

	Name:	 	Dan Halvorson
	
	  

	Name:	 	Michelle McKenna
	
	  

	Name:	 	Vipul Patel
	
	  

	Name:	 	Monica Reed
	
	  

	Name:	 	Allen Weiss
	
	  

	Name:	 	Robert Whitehead

 [Signature Page to Sponsor Support Agreement] 

 
			
	PARENT:
	
	ISLEWORTH HEALTHCARE ACQUISITION CORP.
		
	By:	 	  

	Name:	 	Robert Whitehead
	Title:	 	Chief Executive Officer

 [Signature Page to Sponsor Support Agreement] 

 
			
	COMPANY:
	
	CYTOVIA HOLDINGS, INC.
		
	By:	 	  

	Name:	 	Daniel Teper
	Title:	 	Chief Executive Officer

 [Signature Page to Sponsor Support Agreement] 

 Schedule I 

Sponsor Parent Common Stock and Parent Warrants 
  

									
	 Sponsor
	  	Parent Common Shares	 	 	Parent Warrants	 
	 Isleworth Healthcare Sponsor I, LLC

 
 c/o Isleworth Healthcare Acquisition Corp.

360 Central Avenue, First Central Tower, Suite 800, St. Petersburg, Florida 33701
	  	 	5,067,000	 	 	 	4,912,000	 
	 W. Robert Dahl
  

c/o Isleworth Healthcare Acquisition Corp.

360 Central Avenue, First Central Tower, Suite 800, St. Petersburg, Florida 33701
	  	 	36,000	 	 	 	—  	 
	 Dan Halvorson
  

c/o Isleworth Healthcare Acquisition Corp.

360 Central Avenue, First Central Tower, Suite 800, St. Petersburg, Florida 33701
	  	 	—  	(1) 	 	 	—  	(1) 
	 Michell McKenna
  

c/o Isleworth Healthcare Acquisition Corp.

360 Central Avenue, First Central Tower, Suite 800, St. Petersburg, Florida 33701
	  	 	36,000	 	 	 	—  	 
	 Vipul Patel
  

c/o Isleworth Healthcare Acquisition Corp.

360 Central Avenue, First Central Tower, Suite 800, St. Petersburg, Florida 33701
	  	 	—  	(1) 	 	 	—  	(1) 
	 Monica Reed
  

c/o Isleworth Healthcare Acquisition Corp.

360 Central Avenue, First Central Tower, Suite 800, St. Petersburg, Florida 33701
	  	 	36,000	 	 	 	—  	 
	 Allen Weiss
  

c/o Isleworth Healthcare Acquisition Corp.

360 Central Avenue, First Central Tower, Suite 800, St. Petersburg, Florida 33701
	  	 	—  	(1) 	 	 	—  	(1) 
	 Robert Whitehead
  

c/o Isleworth Healthcare Acquisition Corp.

360 Central Avenue, First Central Tower, Suite 800, St. Petersburg, Florida 33701
	  	 	5,067,000 	(2) 	 	 	5,067,000 	(2) 

  

  
 [Schedule I to Sponsor
Support Agreement] 

	(1)	 Each of these individuals hold an interest in Sponsor Holdco. Each such person disclaims any beneficial
ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly. 

  

	(2)	 Consists of shares and warrants held by Sponsor Holdco, of which Mr. Whitehead is the sole manager.

  
 [Schedule I to Sponsor
Support Agreement] 

 Schedule II 

Affiliate Agreements 
 Administrative
Services Agreement, dated February 24, 2021, by and between Parent and RSW Consultants, LLC 

  
 [Schedule II to Sponsor
Support Agreement]EX-10.2

 Exhibit 10.2 

FORM OF STOCKHOLDER SUPPORT AGREEMENT 

This Stockholder Support Agreement (this “Agreement”) is dated as of April 26, 2022, by and among Isleworth
Healthcare Acquisition Corp., a Delaware corporation (“Parent”), the persons set forth on Schedule I hereto (each, a “Company Stockholder” and, collectively, the “Company
Stockholders”), and Cytovia Holdings, Inc., a Delaware corporation (the “Company”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement
(as defined below). 
 RECITALS 

WHEREAS, as of the date hereof, the Company Stockholders are the holders of record and “beneficial owners” (within the meaning of
Rule 13d-3 of the Exchange Act) of such number of shares of Company Common Stock and Company Preferred Stock as are indicated opposite each of their names on Schedule I attached hereto (all such shares
of Company Common Stock and Company Preferred Stock, together with any shares of Company Common Stock or Company Preferred Stock of which ownership of record or the power to vote (including, without limitation, by proxy or power of attorney) is
hereafter acquired by any such Company Stockholder during the period from the date hereof through the Expiration Time are referred to herein as the “Subject Shares”); 

WHEREAS, concurrently with the execution of this Agreement, Parent, IHAC First Merger Sub Inc., a Delaware corporation (“First
Merger Sub”), IHAC Second Merger Sub LLC, a Delaware limited liability company (“Second Merger Sub”), and the Company entered into a Merger Agreement and Plan of Reorganization (as amended or modified from time
to time, the “Merger Agreement”) pursuant to which, among other transactions, First Merger Sub will merge with and into the Company (the “First Merger”), with the Company surviving the First Merger as
a wholly owned subsidiary of Parent (the Company, in its capacity as the surviving corporation of the First Merger, is sometimes referred to as the “Surviving Corporation”), and immediately following the First Merger, the
Surviving Corporation will merge with and into Second Merger Sub (the “Second Merger” and, together with the First Merger, the “Mergers”), with Second Merger Sub being the surviving entity of the
Second Merger; and each share of Company Preferred Stock that is issued and outstanding immediately prior to the Effective Time will be automatically converted into a number of shares of Company Common Stock at the then-effective conversion rate as
calculated pursuant to the Company Charter (the “Company Preferred Conversion”), and each share of Company Common Stock (including shares of Company Common Stock resulting from the Company Preferred Conversion and shares of
Company Restricted Stock) that is issued and outstanding immediately prior to the Effective Time will be canceled and converted into the right to receive a certain number of shares of Parent Common Stock pursuant, and subject to, the terms of the
Merger Agreement; and 
 WHEREAS, as an inducement to Parent and the Company to enter into the Merger Agreement and to consummate the
Transactions, the parties hereto desire to agree to certain matters as set forth herein. 

 AGREEMENT 

NOW, THEREFORE, in consideration of the foregoing and the mutual agreements contained herein, and intending to be legally bound hereby, the
parties hereto hereby agree as follows: 
 ARTICLE I 

STOCKHOLDER SUPPORT AGREEMENT; COVENANTS 

Section 1.1    No Transfer. During the period commencing on the date hereof and ending on the earlier to occur
of (a) the Effective Time, and (b) such date and time as the Merger Agreement shall be terminated in accordance with Section 9.01 thereof (the earlier of (a) and (b), the “Expiration Time”), each Company
Stockholder shall not (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, file (or participate in the filing of) a
registration statement with the SEC (other than the Proxy Statement and Registration Statement) or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the
Exchange Act, with respect to any Subject Shares, (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject Shares (each transaction specified in
clauses (i) and (ii), a “Transfer”) or (iii) publicly announce any intention to effect any transaction specified in clause (i) or (ii); provided, however, that (x) a Company Stockholder may
Transfer his, her or its Subject Shares to any other Company Stockholder that has entered into or otherwise agreed to be bound by this Agreement, or (y) (A) if a Company Stockholder is an individual, such Company Stockholder may Transfer any
such Subject Shares (1) to any member of such Company Stockholder’s immediate family, or to a trust for the benefit of such Company Stockholder or any member of such Company Stockholder’s immediate family, the sole trustees of which
are such Company Stockholder or any member of such Company Stockholder’s immediate family or (2) by will, other testamentary document or under the laws of intestacy upon the death of such Company Stockholder; or (B) if a Company
Stockholder is an entity, such Company Stockholder may Transfer any Subject Shares to any partner, member, or affiliate of such Company Stockholder in accordance with the terms of the Company Charter; provided further, that in each
case such transferee of such Subject Shares evidences in a writing reasonably satisfactory to Parent such transferee’s agreement to be bound by and subject to the terms and provisions hereof to the same extent as such transferring Company
Stockholder. 
 Section 1.2    New Shares. In the event that, during the period commencing on the date
hereof and ending at the Expiration Time, (a) any Subject Shares are issued to a Company Stockholder after the date of this Agreement pursuant to any stock dividend, stock split, recapitalization, reclassification, combination or exchange of
Subject Shares or otherwise, (b) a Company Stockholder purchases or otherwise acquires beneficial ownership of any Subject Shares or (c) a Company Stockholder acquires the right to vote or share in the voting of any Subject Shares
(collectively, the “New Securities”), then such New Securities acquired or purchased by such Company Stockholder shall be subject to the terms of this Agreement to the same extent as if they constituted the Subject Shares
owned by such Company Stockholder as of the date hereof. 

  
 2 

 Section 1.3    Stockholder Agreements. Hereafter
until the Expiration Time, each Company Stockholder hereby unconditionally and irrevocably agrees that, at any meeting of the stockholders of the Company (or any adjournment or postponement thereof), and in any action by written consent of the
stockholders of the Company requested by the Company Board or otherwise undertaken as contemplated by the Transactions (which written consent shall be delivered promptly, and in any event within three (3) Business Days, after the Registration
Statement (as contemplated by the Merger Agreement) becomes effective), such Company Stockholder shall, if a meeting is held, appear at the meeting, in person or by proxy, or otherwise cause its Subject Shares to be counted as present thereat for
purposes of establishing a quorum, and such Company Stockholder shall vote or provide consent (or cause to be voted or consented), in person or by proxy, all of its Subject Shares: 

(a)    to approve and adopt the Merger Agreement, the other Transaction Documents and the Transactions; 

(b)    to the extent such Company Stockholder’s Subject Shares include shares of Company Preferred Stock, to
authorize and approve the Company Preferred Conversion; 
 (c)    in any other circumstances upon which a consent or
other approval is required under the Company Charter or otherwise sought with respect to the Merger Agreement or the Transactions, to vote, consent or approve (or cause to be voted, consented or approved) all of such Company Stockholder’s
Subject Shares held at such time in favor thereof; 
 (d)    against and withhold consent with respect to any merger,
purchase of all or substantially all of the Company’s assets or other business combination transaction (other than the Merger Agreement and the Transactions); 

(e)    against any proposal, action or agreement that would (i) impede, frustrate, prevent or nullify any provision
of this Agreement, the Merger Agreement or any Merger, (ii) result in a breach in any respect of any covenant, representation, warranty or any other obligation or agreement of the Company under the Merger Agreement or (iii) result in any
of the conditions set forth in Article VIII of the Merger Agreement not being fulfilled prior to the Outside Date; and 

(f)     to approve or authorize (or to vote against or withhold consent for, as applicable) any other matters necessary
or reasonably requested by the Company or Parent for the consummation of the Transactions; 
 provided, however, that such Company Stockholder
shall not vote or provide consent with respect to any of its Subject Shares that are not held by the Company’s directors, officers, affiliates or greater than 5% shareholders of the Company, or take any other action, in each case to the extent
any such vote, consent or other action would preclude Parent from filing the Registration Statement with the SEC as contemplated by the Merger Agreement. Each Company Stockholder hereby agrees that it shall not commit or agree to take any action
inconsistent with the foregoing prior to the Expiration Time. 

  
 3 

 Section 1.4    No Challenges. Each Company Stockholder
agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Parent, First Merger Sub, Second
Merger Sub, the Company or any of their respective successors or directors (a) challenging the validity of, or seeking to enjoin the operation of, any provision of this Agreement or (b) alleging a breach of any fiduciary duty of any person
in connection with the evaluation, negotiation or entry into the Merger Agreement. Each Company Stockholder hereby irrevocably and unconditionally waives, and agrees not to assert, exercise or perfect (or attempt to exercise, assert or perfect), any
rights of appraisal or rights to dissent from the First Merger or appraisal or dissenters’ rights that it may at any time have under applicable Laws, including Section 262 of the DGCL. 

Section 1.5    Affiliate Agreements. Each Company Stockholder hereby agrees and consents to the termination of
(i) that certain Investors’ Rights Agreement, dated as of September 12, 2021, as amended, by and among the Company and the other parties thereto (the “Investors’ Rights Agreement”); (ii) that certain Right
of First Refusal and Co-Sale Agreement, dated as of September 12, 2021, as amended, by and among the Company and the other parties thereto (the “RoFR and
Co-Sale Agreement”); (iii) those agreements set forth on Schedule II (the “Other Stockholder Agreements” and, together with the Investors’ Rights Agreement and
the RoFR and Co-Sale Agreement, the “Investment Agreements”); and (iv) any other Contracts set forth on Section 4.20 of the Company Disclosure Schedule to which such Company
Stockholder is party and any other Contract contemplated by Section 7.19 of the Merger Agreement to which such Company Stockholder is a Party, except for the contracts set forth on Section 7.19 of the Company Disclosure Schedule, in each
case of the foregoing clauses (i) through (iv), effective as of the Effective Time without any further liability or obligation to the Company, the Company’s Subsidiaries, Parent, First Merger Sub or Second Merger Sub. The Company and each
Company Stockholder hereby waives any right to notice, right to consent to transfer, right of first offer, right of first refusal or similar rights with respect to the disposition of any shares of Capital Stock in the Transactions, in each case that
the Company or such Company Stockholder may have under any Investment Agreement or under the Company Organizational Documents. 

Section 1.6    Binding Effect of Merger Agreement. Each Company Stockholder shall be bound by and comply with
Sections 7.05(a) (Non-Solicitation) and 7.11 (Public Announcements) of the Merger Agreement (and any relevant definitions contained in any such Sections) as if (a) such Company Stockholder
was an original signatory to the Merger Agreement with respect to such provisions, and (b) each reference to the “Company” contained in Section 7.05(a) of the Merger Agreement (other than for purposes of the definition of
Acquisition Proposal) also referred to each such Company Stockholder. 
 Section 1.7    Certain Covenants of
Company Stockholders. 
 (a)    Registration Rights. Each of the Company Stockholders set forth on
Schedule III will deliver, substantially simultaneously with the Effective Time, a duly-executed copy of the Registration Rights Agreement, in a form to be agreed to by the parties. 

(b)    Post-Closing Lock-Up. Each Company Stockholder hereby acknowledges
that the Amended and Restated Bylaws of Parent in a form to be agreed by the 

  
 4 

 
parties (the “Amended Bylaws”) shall provide that the shares of Parent Common Stock issued in the Aggregate Merger Consideration will be subject to Transfer restrictions
(i.e., a “lock-up”) following the Closing. Each Company Stockholder hereby agrees to be bound by and comply such Transfer restrictions in the Amended Bylaws as if such section was set forth
herein and made a part hereof. 
 Section 1.8    Further Assurances. Each Company Stockholder shall execute
and deliver, or cause to be delivered, such additional documents, and take, or cause to be taken, all such further actions and do, or cause to be done, all things reasonably necessary (including under applicable Laws), or reasonably requested by
Parent or the Company, to effect the actions and consummate the Mergers and the other transactions contemplated by this Agreement and the Merger Agreement (including the Transactions), in each case, on the terms and subject to the conditions set
forth therein and herein, as applicable. 
 Section 1.9    No Inconsistent Agreement. Each Company
Stockholder hereby represents and covenants that such Company Stockholder (i) has not entered into, and shall not enter into, any voting agreement, voting trust or other agreement with respect to any of such Company Stockholder’s Subject
Shares that is inconsistent with such Company Stockholder’s obligations pursuant to this Agreement or any agreement or amendment of an existing agreement that would restrict, limit or interfere with the performance of such Company
Stockholder’s obligations hereunder, and (ii) has not granted, and shall not grant, a proxy, power of attorney or similar right with respect to any of such Company Stockholder’s Subject Shares that is inconsistent with such Company
Stockholder’s obligations pursuant to this Agreement. 
 Section 1.10    Consent to Disclosure. Each
Company Stockholder hereby consents to the publication and disclosure in the Proxy Statement and Registration Statement (and, as and to the extent otherwise required by applicable securities Laws or the SEC or any other securities authorities, any
other documents or communications provided by Parent or the Company to any Governmental Authority or to securityholders of Parent) of such Company Stockholder’s identity and beneficial ownership of Subject Shares and the nature of such Company
Stockholder’s commitments, arrangements and understandings under and relating to this Agreement and, if deemed appropriate by Parent or the Company, a copy of this Agreement. Each Company Stockholder will promptly provide any information
reasonably requested by Parent or the Company for any regulatory application or filing made or approval sought in connection with the Transactions (including filings with the SEC). 

Section 1.11    Irrevocable Proxy. Upon the failure of a Company Stockholder to provide its consent or vote
its Subject Shares in accordance with Section 1.3 of this Agreement pursuant to any action by written consent of the stockholders of the Company requested by the Company Board or otherwise undertaken as contemplated by the
Transactions or at any applicable meeting of the stockholders of the Company, such Company Stockholder shall be deemed to have irrevocably granted to, and appointed, the Company, and any designee thereof, and each of them individually, as such
Company Stockholder’s proxy and attorney-in-fact (with full power of substitution), for and in such Company Stockholder’s name, place and stead, to include
such Subject Shares in any computation for purposes of establishing a quorum at any such meeting of the stockholders of the Company and to provide consent or vote such Company Stockholder’s Subject Shares in any action by written consent of the
stockholders of the Company or at any 

  
 5 

 
meeting of the stockholders of the Company called with respect to any of the matters specified in, and in accordance and consistent with, Section 1.3 of this Agreement.
The Company Stockholder hereby affirms that the irrevocable proxy is coupled with an interest and may under no circumstances be revoked and that such irrevocable proxy is executed and intended to be irrevocable. Notwithstanding any other provision
of this Agreement, the irrevocable proxy granted hereunder shall automatically terminate upon the termination of this Agreement. 

Section 1.12    Release of Claims. Effective as of, and conditioned upon occurrence of, the Closing, each
Company Stockholder, for himself, herself or itself and on behalf of each of his, her or its Affiliates and each of their respective successors (each, a “Releasing Party”), hereby unequivocally, voluntarily, knowingly,
willingly, unconditionally, completely and, irrevocably releases, acquits, exculpates and forever waives and relinquishes all claims, suits, debts, demands, liabilities, setoffs, counterclaims, actions, manners of action and causes of action of
whatever kind or nature, whether known or unknown (collectively, “Claims”), which any Releasing Party has, may have or might have or may assert now or in the future, against the Company and its Subsidiaries and their
respective Representatives (in each case, solely in their capacity as such), successors and permitted assigns, and, after the Closing, Parent and its Subsidiaries, and each of their respective officers, directors, owners, partners, managers or
employees (in each case, solely in their capacity as such) (collectively, the “Released Parties”) to the extent arising out of, based upon or resulting from any Contract, transaction, event, circumstance, action, failure to
act or occurrence of any sort or type, whether known or unknown, and which, in each and every case, occurred, existed, was taken, permitted, incurred or begun at or prior to the Closing, in each case solely with regard to the Company, the business
or operations of the Company prior to the Closing or the Transactions; provided that nothing contained in this Section 1.12 shall be construed as a waiver of any rights under (i) this Agreement, (ii) any
other Transaction Document to which any Releasing Party is party, (iii) if such Company Stockholder is an employee of the Company, rights to accrued but unpaid salary, bonuses, expense reimbursements (in accordance with the Company’s
employee expense reimbursement policy), accrued vacation and other benefits under the Company’s employee benefit plans, or (iv) any indemnification, employment or other similar arrangements (including any such arrangement providing for
exculpation or advancement of expenses), including any rights to indemnification, exculpation, advancement of expense or similar rights set forth in the Company Organizational Documents, any indemnification agreement between the Company and such
Company Stockholder, or as provided by law or any directors’ and officers’ liability insurance. 
 ARTICLE II 

REPRESENTATIONS AND WARRANTIES 

Section 2.1    Representations and Warranties of the Company Stockholders. Each Company Stockholder represents
and warrants as of the date hereof to Parent and the Company (solely with respect to itself, himself or herself and not with respect to any other Company Stockholder) as follows: 

(a)    Organization; Due Authorization. If such Company Stockholder is not an individual, it is duly organized,
validly existing and in good standing under the Laws of the jurisdiction in which it is incorporated, formed, organized or constituted, and the execution, delivery and performance of this Agreement and the consummation of the transactions

  
 6 

 
contemplated hereby are within such Company Stockholder’s corporate, limited liability company or organizational powers and have been duly authorized by all necessary corporate, limited
liability company or organizational actions on the part of such Company Stockholder. If such Company Stockholder is an individual, such Company Stockholder has full legal capacity, right and authority to execute and deliver this Agreement and to
perform his or her obligations hereunder. This Agreement has been duly executed and delivered by such Company Stockholder and, assuming due authorization, execution and delivery by the other parties to this Agreement, this Agreement constitutes a
legally valid and binding obligation of such Company Stockholder, enforceable against such Company Stockholder in accordance with the terms hereof (subject to the Remedies Exceptions). If this Agreement is being executed in a representative or
fiduciary capacity, the person signing this Agreement has full power and authority to enter into this Agreement on behalf of the applicable Company Stockholder. 

(b)    Ownership. Such Company Stockholder is the record and beneficial owner (as defined in the Securities Act)
of, and has good title to, all of such Company Stockholder’s Subject Shares, and there exist no Liens or any other limitation or restriction (including any restriction on the right to vote, sell or otherwise dispose of such Subject Shares
(other than transfer restrictions under the Securities Act) affecting any such Subject Shares, other than Liens pursuant to (i) this Agreement, (ii) the Company Charter, (iii) the Merger Agreement, or (iv) any applicable
securities Laws. Such Company Stockholder’s Subject Shares are the only equity securities in the Company owned of record or beneficially by such Company Stockholder on the date of this Agreement, and none of such Company Stockholder’s
Subject Shares are subject to any proxy, voting trust or other agreement or arrangement with respect to the voting of such Subject Shares, except as provided hereunder and under the Investment Agreements. Other than the Company Warrants or Company
RSUs set forth opposite such Company Stockholder’s name on Schedule I, such Company Stockholder does not hold or own any rights to acquire (directly or indirectly) any equity securities of the Company or any equity securities convertible
into, or which can be exchanged for, equity securities of the Company. 
 (c)    No Conflicts. The execution and
delivery of this Agreement by such Company Stockholder does not, and the performance by such Company Stockholder of his, her or its obligations hereunder will not, (i) if such Company Stockholder is not an individual, conflict with or result in
a violation of the organizational documents of such Company Stockholder or (ii) require any consent or approval that has not been given or other action that has not been taken by any person (including under any Contract binding upon such
Company Stockholder or such Company Stockholder’s Subject Shares) to the extent such consent, approval or other action would prevent, enjoin or materially delay the performance by such Company Stockholder of its, his or her obligations under
this Agreement. 
 (d)    Litigation. There are no Actions pending against such Company Stockholder, or to the
knowledge of such Company Stockholder threatened against such Company Stockholder, before (or, in the case of threatened Actions, that would be before) any arbitrator or any Governmental Authority, which in any manner challenges or seeks to prevent,
enjoin or materially delay the performance by such Company Stockholder of its, his or her obligations under this Agreement. 

  
 7 

 (e)    Adequate Information. Such Company Stockholder is a
sophisticated stockholder and has adequate information concerning the business and financial condition of Parent and the Company to make an informed decision regarding this Agreement and the Transactions and has independently and without reliance
upon Parent or the Company and based on such information as such Company Stockholder has deemed appropriate, made its own analysis and decision to enter into this Agreement. Such Company Stockholder acknowledges that Parent and the Company have not
made and do not make any representation or warranty, whether express or implied, of any kind or character except as expressly set forth in this Agreement. Such Company Stockholder acknowledges that the agreements contained herein with respect to the
Subject Shares held by such Company Stockholder are irrevocable. 
 (f)    Brokerage Fees. Except as set forth
on Section 4.22 of the Company Disclosure Schedule, no broker, finder, investment banker or other person is entitled to any brokerage fee, finders’ fee or other commission in connection with the Transactions based upon arrangements made by
such Company Stockholder, for which the Company or any of its Subsidiaries may become liable. 

(g)    Acknowledgment. Such Company Stockholder understands and acknowledges that each of Parent and the Company
is entering into the Merger Agreement in reliance upon such Company Stockholder’s execution and delivery of this Agreement. 

ARTICLE III 

MISCELLANEOUS 

Section 3.1    Termination. This Agreement and all of its provisions shall terminate and be of no further
force or effect upon the earlier of (i) the Expiration Time and (ii) as to each Company Stockholder, the written agreement of Parent, the Company and such Company Stockholder. Upon such termination of this Agreement, all obligations of the
parties under this Agreement will terminate, without any liability or other obligation on the part of any party hereto to any person in respect hereof or the transactions contemplated hereby, and no party hereto shall have any claim against another
(and no person shall have any rights against such party), whether under contract, tort or otherwise, with respect to the subject matter hereof; provided, however, that the termination of this Agreement shall not relieve any party
hereto from liability arising in respect of any breach of this Agreement prior to such termination. This ARTICLE III shall survive the termination of this Agreement. 

Section 3.2    Governing Law. This Agreement shall be governed by, and construed in accordance with, the Laws
of the State of Delaware applicable to contracts executed in and to be performed in that State. All legal actions and proceedings arising out of or relating to this Agreement shall be heard and determined exclusively in any Delaware Chancery Court;
provided that, if jurisdiction is not then available in the Delaware Chancery Court, then any such legal Action may be brought in any federal court located in the State of Delaware or any other Delaware state court. The parties hereto hereby
(a) irrevocably submit to the exclusive jurisdiction of the aforesaid courts for themselves and with respect to their respective properties for the purpose of any Action arising out of or relating to this Agreement brought by any party hereto,
and (b) agree not to commence any Action relating thereto except in the courts described above in Delaware, other than Actions in any court of competent jurisdiction to enforce any judgment, decree or award

  
 8 

 
rendered by any such court in Delaware as described herein. Each of the parties further agrees that notice as provided herein shall constitute sufficient service of process and the parties
further waive any argument that such service is insufficient. Each of the parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Action arising out of or
relating to this Agreement or the transactions contemplated hereby, (i) any claim that it is not personally subject to the jurisdiction of the courts in Delaware as described herein for any reason, (ii) that it or its property is exempt or
immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and
(iii) that (x) the Action in any such court is brought in an inconvenient forum, (y) the venue of such Action is improper or (z) this Agreement, or the subject matter hereof, may not be enforced in or by such courts. 

Section 3.3    WAIVER OF JURY TRIAL. Each of the parties hereto hereby waives to the fullest extent permitted
by applicable Law any right it may have to a trial by jury with respect to any litigation directly or indirectly arising out of, under or in connection with this Agreement or the Transactions. Each of the parties hereto (a) certifies that no
representative, agent or attorney of any other party has represented, expressly or otherwise, that such other party would not, in the event of litigation, seek to enforce that foregoing waiver and (b) acknowledges that it and the other hereto
have been induced to enter into this Agreement and the Transactions, as applicable, by, among other things, the mutual waivers and certifications in this Section 3.3. 

Section 3.4    Assignment. This Agreement and all of the provisions hereof will be binding upon and inure to
the benefit of the parties hereto and their respective heirs, successors and permitted assigns. Neither this Agreement nor any of the rights, interests or obligations hereunder will be assigned (including by operation of law) without the prior
written consent of the parties hereto. 
 Section 3.5    Specific Performance. The parties agree that
irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof, and, accordingly, that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement or
to enforce specifically the performance of the terms and provisions hereof in the Court of Chancery of the State of Delaware or, if that court does not have jurisdiction, any court of the United States located in the State of Delaware without proof
of actual damages or otherwise, in addition to any other remedy to which they are entitled at law or in equity as expressly permitted in this Agreement. Each of the parties hereby further waives (i) any defense in any action for specific
performance that a remedy at law would be adequate and (ii) any requirement under any Law to post security or a bond as a prerequisite to obtaining equitable relief. 

Section 3.6    Amendment; Waiver. This Agreement may not be amended, changed, supplemented, waived or
otherwise modified or terminated, except upon the execution and delivery of a written agreement executed by Parent, the Company and the Company Stockholders. 

Section 3.7    Severability. If any provision of this Agreement is held invalid or unenforceable by any court
of competent jurisdiction, the other provisions of this Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable 

  
 9 

 
only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable. 

Section 3.8    Notices. All notices, requests, claims, demands and other communications hereunder shall be in
writing and shall be given (and shall be deemed to have been duly given upon receipt) by delivery in person, by email or by registered or certified mail (postage prepaid, return receipt requested) to the respective parties at the following addresses
(or at such other address for a party as shall be specified in a notice given in accordance with this Section 3.8: 

If to Parent: 
 Isleworth
Healthcare Acquisition Corp. 
 360 Central Avenue, First Central Tower, Suite 800 

St. Petersburg, Florida 33701 

Attention: Dan Halvorson 
 Email:
dan@isleworthhealthcare.com 
 with a copy to (which will not constitute notice): 

ArentFox Schiff LLP 
 1717 K
Street NW 
 Washington, DC 20006 

Attention: Ralph V. De Martino 

Email: RDeMartino@schiffhardin.com 

If to the Company: 

Cytovia Holdings, Inc. 
 18851 NE
29th Ave, 2nd Floor 
 Aventura, Florida 33180 

Attention: Elysa Mantel 
 Email:
emantel@cytoviatx.com 
 with a copy to (which shall not constitute notice): 

Cooley LLP 
 55 Hudson Yards 

New York, NY 10001-2157 

Attention: Josh Kaufman and David Silverman 

Email: josh.kaufman@cooley.com and dsilverman@cooley.com 

If to a Company Stockholder: 

To such Company Stockholder’s notice information set forth in Schedule I. 

  
 10 

 Section 3.9    Counterparts. This Agreement may be executed
in two or more counterparts (any of which may be delivered by electronic transmission), each of which shall constitute an original, and all of which taken together shall constitute one and the same instrument. 

Section 3.10    Entire Agreement. This Agreement and the agreements referenced herein constitute the entire
agreement and understanding of the parties hereto in respect of the subject matter hereof and supersede all prior understandings, agreements or representations by or among the parties hereto to the extent they relate in any way to the subject matter
hereof. 
 [THE REMAINDER OF THIS PAGE IS INTENTIONALLY BLANK] 

  
 11 

 IN WITNESS WHEREOF, the Company Stockholders, Parent, and the Company have each caused this
Stockholder Support Agreement to be duly executed as of the date first written above. 
  

			
	COMPANY STOCKHOLDERS:
	
	[NAME]

 
			
		
	 By:
	 	  

	 Name:
	 	
	 Title:
	 	

  
 [Signature Page to
Stockholder Support Agreement] 

 
			
	PARENT:
	
	ISLEWORTH HEALTHCARE ACQUISITION CORP.
		
	By:	 	  

	Name:	 	Robert Whitehead
	Title:	 	Chief Executive Officer

  
 [Signature Page to
Stockholder Support Agreement] 

 
			
	COMPANY:
	
	CYTOVIA HOLDINGS, INC.
		
	By:	 	  

	Name:	 	Daniel Teper
	Title:	 	Chief Executive Officer

  
 [Signature Page to
Stockholder Support Agreement] 

 Schedule I 

Company Stockholder Subject Shares 
  

																									
	Holder	  	Shares of
Company
Class A Common
Stock	 	  	Shares of
Company
Class B
Common
Stock	 	  	Shares of
Company
Preferred
Stock	 	  	Company
RSUs	 	  	Company
Warrants	 	  	Notice
Information	 
	             
	  	 	                        	 	  	 	            	 	  	 	                	 	  	 	            	 	  	 	                	 	  	 	            	 

  

  
 [Schedule I to
Stockholder Support Agreement] 

 Schedule II 

Other Investor Agreements 
 None. 

 

  
 [Schedule II to
Stockholder Support Agreement] 

 Schedule III 

Certain Stockholders 
  

	1.	 Daniel Teper 

  

	2.	 Teper 2020 Family Trust 

 

	3.	 Gilles Seydoux 

  

	4.	 The Seydoux 2020 Family Trust 

 

	5.	 TFYF Limited 

  

	6.	 Jean Kadouche 

  

	7.	 Ramax Investissements 

 

	8.	 Wei Li 

  

	9.	 Thomas H. Robinson 

  

	10.	 Massimo Radaelli 

  

	11.	 Stanley Frankel 

  

	12.	 Melini Capital 

  

	13.	 TF Capital IV Ltd. 

  

	14.	 Laurent Audoly 

  

	15.	 CTI Investors LLC 

  

	16.	 Michael Friedman 

  

	17.	 Leila Alland 

  

	18.	 Jason Aryeh 

  

	19.	 Anna Baran-Djokovic 

 

  
 [Schedule III to
Stockholder Support Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]